Literature DB >> 10984433

Distinct roles for pbs21 and pbs25 in the in vitro ookinete to oocyst transformation of Plasmodium berghei.

I Sidén-Kiamos1, D Vlachou, G Margos, A Beetsma, A P Waters, R E Sinden, C Louis.   

Abstract

We have developed an in vitro culture system for early sporogonic stages of Plasmodium berghei, which can be used to study developmental events normally taking place in the midgut of an infected mosquito. These include penetration of insect cells by the mature ookinete, transformation into oocysts and the early development of the latter, sustained through several rounds of nuclear division. The system, based upon co-culture of enriched ookinetes with several established insect cell lines, was used to study the development of mutant ookinetes lacking both the Pbs21 and Pbs25 surface proteins. Motility and entry of double knockout and Pbs21 single knockout ookinetes into the insect cells are normal, but the number of ookinetes successfully transforming into oocysts expressing the CSP protein are substantially reduced. Finally, using the yeast two-hybrid system we also show that Pbs25 has the capacity to homodimerise as well as to form heterodimers with Pbs21.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984433     DOI: 10.1242/jcs.113.19.3419

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  22 in total

Review 1.  Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines.

Authors:  Ajay K Saxena; Yimin Wu; David N Garboczi
Journal:  Eukaryot Cell       Date:  2007-06-08

2.  PbCap380, a novel oocyst capsule protein, is essential for malaria parasite survival in the mosquito.

Authors:  Prakash Srinivasan; Hisashi Fujioka; Marcelo Jacobs-Lorena
Journal:  Cell Microbiol       Date:  2008-02-01       Impact factor: 3.715

Review 3.  Malaria adhesins: structure and function.

Authors:  Brian M Malpede; Niraj H Tolia
Journal:  Cell Microbiol       Date:  2014-03-06       Impact factor: 3.715

4.  A constitutive pan-hexose permease for the Plasmodium life cycle and transgenic models for screening of antimalarial sugar analogs.

Authors:  Martin Blume; Marion Hliscs; Dayana Rodriguez-Contreras; Marco Sanchez; Scott Landfear; Richard Lucius; Kai Matuschewski; Nishith Gupta
Journal:  FASEB J       Date:  2010-12-17       Impact factor: 5.191

5.  Arrested oocyst maturation in Plasmodium parasites lacking type II NADH:ubiquinone dehydrogenase.

Authors:  Katja E Boysen; Kai Matuschewski
Journal:  J Biol Chem       Date:  2011-07-19       Impact factor: 5.157

6.  Gambicin: a novel immune responsive antimicrobial peptide from the malaria vector Anopheles gambiae.

Authors:  J Vizioli; P Bulet; J A Hoffmann; F C Kafatos; H M Müller; G Dimopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

7.  High mobility group protein HMGB2 is a critical regulator of plasmodium oocyst development.

Authors:  Mathieu Gissot; Li-Min Ting; Thomas M Daly; Lawrence W Bergman; Photini Sinnis; Kami Kim
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

8.  Multiple pathways for Plasmodium ookinete invasion of the mosquito midgut.

Authors:  Joel Vega-Rodríguez; Anil K Ghosh; Stefan M Kanzok; Rhoel R Dinglasan; Sibao Wang; Nicholas J Bongio; Dario E Kalume; Kazutoyo Miura; Carole A Long; Akhilesh Pandey; Marcelo Jacobs-Lorena
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

9.  Regulation of sexual development of Plasmodium by translational repression.

Authors:  Gunnar R Mair; Joanna A M Braks; Lindsey S Garver; Joop C A G Wiegant; Neil Hall; Roeland W Dirks; Shahid M Khan; George Dimopoulos; Chris J Janse; Andrew P Waters
Journal:  Science       Date:  2006-08-04       Impact factor: 63.714

10.  Localisation of laminin within Plasmodium berghei oocysts and the midgut epithelial cells of Anopheles stephensi.

Authors:  Adéla Nacer; Karen Walker; Hilary Hurd
Journal:  Parasit Vectors       Date:  2008-09-22       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.